RNAC Insider Trading Activity and SEC Form 4 Filings
RNAC insider trading summary
Over the past 12 months, insiders at Cartesian Therapeutics, Inc. (RNAC) reported 3 sales worth $259K by 3 insiders and 1 open-market purchase worth $206K by 1 insider on SEC Form 4. Net insider selling was $53K.
Latest RNAC insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 6, 2026 | Milos Miljkovic | Chief Medical Officer | Sell | $24K (3,573 @ $6.82) |
| Jan 6, 2026 | Blaine Davis | Chief Financial Officer | Sell | $72K (10,591 @ $6.82) |
| Jan 6, 2026 | Carsten Brunn | President and CEO | Sell | $162K (23,766 @ $6.82) |
| Dec 4, 2025 | Timothy C Barabe | Director | Buy | $206K (30,000 @ $6.86) |
| Apr 11, 2025 | Timothy A Springer | Director | Buy | $391K (36,338 @ $10.77) |
| Apr 11, 2025 | Timothy A Springer | Director | Buy | $69K (6,412 @ $10.77) |
| Apr 10, 2025 | Timothy A Springer | Director | Buy | $7K (609 @ $10.92) |
| Apr 10, 2025 | Timothy A Springer | Director | Buy | $83K (7,966 @ $10.43) |
| Apr 10, 2025 | Timothy A Springer | Director | Buy | $38K (3,451 @ $10.92) |
| Apr 10, 2025 | Timothy A Springer | Director | Buy | $471K (45,144 @ $10.43) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.